Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Patent Reform Provision Extending Angiomax Patent Would Cost $1 Bil. – CBO
Feb 25 2008
•
By
Brenda Sandburg
More from Archive
More from Pink Sheet